The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(E)-N'-(3-bromo-4-hydroxy-5-methoxybenzylidene)isonicotinohydrazide ID: ALA3394898
PubChem CID: 135533118
Max Phase: Preclinical
Molecular Formula: C14H12BrN3O3
Molecular Weight: 350.17
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(/C=N/NC(=O)c2ccncc2)cc(Br)c1O
Standard InChI: InChI=1S/C14H12BrN3O3/c1-21-12-7-9(6-11(15)13(12)19)8-17-18-14(20)10-2-4-16-5-3-10/h2-8,19H,1H3,(H,18,20)/b17-8+
Standard InChI Key: JEWQUKKWIYZFPE-CAOOACKPSA-N
Molfile:
RDKit 2D
21 22 0 0 0 0 0 0 0 0999 V2000
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0031 -3.0008 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.0432 -3.5993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3383 -1.3500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.3383 1.3500 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
2.5972 1.5031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5951 3.0039 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8933 3.7570 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8912 5.2578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1894 6.0109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8509 5.8560 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1894 7.5110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4884 8.2610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7875 7.5110 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.7875 6.0110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4885 5.2610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
6 7 1 0
7 8 1 0
5 9 1 0
4 10 1 0
2 11 1 0
11 12 2 0
12 13 1 0
13 14 1 0
14 15 1 0
14 16 2 0
15 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 15 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 350.17Molecular Weight (Monoisotopic): 349.0062AlogP: 2.32#Rotatable Bonds: 4Polar Surface Area: 83.81Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.28CX Basic pKa: 3.03CX LogP: 2.05CX LogD: 2.00Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.65Np Likeness Score: -1.20
References 1. Miknis GF, Stevens SJ, Smith LE, Ostrov DA, Churchill ME.. (2015) Development of novel Asf1-H3/H4 inhibitors., 25 (4): [PMID:25582598 ] [10.1016/j.bmcl.2014.11.067 ] 2. Miknis, Greg F; Stevens, Sarah J; Smith, Luke E; Ostrov, David A and Churchill, Mair E A. 2015-02-15 Development of novel Asf1-H3/H4 inhibitors. [PMID:25582598 ]